Raymond James Ups Amsurg to Outperform

Cites factors such as the surgery center operator's stock valuation

Raymond James upgraded Amsurg (AMSG) to outperform from market perform, citing factors such as the surgery center operator's stock valuation.

Analyst John Ransom set a $26 stock price target, which was 18 times his new $1.44 2007 earnings per share (EPS) estimate and 21 times his new $1.23 2006 EPS estimate. Both estimates include a 14 cents per share hit from equity-based compensation.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE